Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway

References

• Tan AC, Ashley DM, López GY, et al. Management of glioblastoma: state of the art and future directions. CA Cancer J Clini. 2020;70(4):299–312. doi:10.3322/caac.21613
   PubMed Web of Science ®Google Scholar
• Chen LH, Pan C, Diplas BH, et al. The integrated genomic and epigenomic landscape of brainstem glioma. Nat commun. 2020;11(1):3077. doi:10.1038/s41467-020-16682-y
   PubMed Web of Science ®Google Scholar
• Wen PY, Weller M, Lee EQ, et al. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020;22(8):1073–1113.
   PubMed Web of Science ®Google Scholar
• Pinto F, Costa ÂM, Andrade RP, Reis RM. Brachyury is associated with glioma differentiation and Response to temozolomide. Neurotherapeutics. 2020;17(4):2015–2027. doi:10.1007/s13311-020-00911-9
   PubMed Web of Science ®Google Scholar
• Duan M, Xing Y, Guo J, et al. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins. Pharmal Biol. 2016;54(12):3009–3018. doi:10.1080/13880209.2016.1199044
   PubMed Web of Science ®Google Scholar
• Ciechomska IA, Marciniak MP, Jackl J, et al. Pre-treatment or post-treatment of human glioma cells with BIX01294, the inhibitor of histone methyltransferase G9a, sensitizes cells to temozolomide. Front Pharmacol. 2018;9:1271. doi:10.3389/fphar.2018.01271
   PubMed Web of Science ®Google Scholar
• Jalota A, Kumar M, Das BC, et al. A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells. Oncotarget. 2018;9(26):18351–18366. doi:10.18632/oncotarget.24839
   PubMedGoogle Scholar
• Li WC, Shen HS, Bai X, et al. In vivo study of traditional Chinese medicine Wenyang Tongqiao effect on rat Glioma mechanism. J Tianjin Univ Trad Chin Med. 2015;03(34):156–159. in Chinese.
   Google Scholar
• Liu CQ, Zhang XFan HW. In vitro pharmacodynamics and prescription analysis on JiuweiTongqiao Decoction in human glioma U251 cell. Chin J Exper Tradit Med Form. 2017;07(23):148–153. in Chinese.
   Google Scholar
• Zhou J, Liu HZhao MR. Clinical research on Naoliu (Brain tumor) powder in treating recurrent brain gliomas. Tianjin J Trad Chin Med. 2008;04:277–280. in Chinese.
   Google Scholar
• Liu JM, Huang LW, Zhu XH, et al. Effects of 3 kinds of serum containing blood-activating and stasis-eliminating TCM compound formulas on JAK/STAT signal pathway of glioma U251 cells. China Pharmacy. 2017;16(28):2176–2179. in Chinese.
   Google Scholar
• Han R, Sun Y, Ma R, et al. Inhibitory effect of volatile oil from RhizomaLigustici Chuanxiong on glioma angiogenesis based on EGFR/VEGF-A signaling pathway. Mod J Integ Trad Chin West Med. 2023;05(32):633–679. in Chinese.
   Google Scholar
• Wu HX. Effects and mechanism of Ligusticum chuanxiong volatile oil in combination with temozolomide in treatment of glioma by regulating P-gp protein. Chin Trad Herb Drug. 2019;22(50):5492–5498. in Chinese.
   Google Scholar
• Ren WG, Guo LL, Zhang CY. Research progress and predictive analysis of quality markers in rhizoma ligustici chuanxiong. Moder Trad Chin Med Mat Med World Sci Technol. 2021;09(23):3307–3314. in Chinese.
   Google Scholar
• Yin J, Wang C, Mody A, et al. The Effect of Z-ligustilide on the mobility of human glioblastoma T98G cells. PLoS One. 2013;8(6):e66598. doi:10.1371/journal.pone.0066598
   PubMed Web of Science ®Google Scholar
• Ma J, Chen X, Chen Y, et al. Ligustilide inhibits tumor angiogenesis by downregulating VEGFA secretion from cancer-associated fibroblasts in prostate cancer via TLR4. Cancers. 2022;14(10):2406. doi:10.3390/cancers14102406
   PubMed Web of Science ®Google Scholar
• Yang JXing Z, Xing Z. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion. Exp. Biol. Med. 2021;246(17):1928–1937. doi:10.1177/15353702211010420
   Web of Science ®Google Scholar
• Diao X, Deng P, Xie C, et al. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation. Drug Metab. Dispos. 2013;41(2):430–444. doi:10.1124/dmd.112.049684
   PubMed Web of Science ®Google Scholar
• Jiang Q, Zhang N, Li X, et al. Dl-3-N-butylphthalide presents anti-cancer activity in lung cancer by targeting PD-1/PD-L1 Signaling. Can Manage Res. 2021;13:8513–8524. doi:10.2147/CMAR.S333416
   Web of Science ®Google Scholar
• Candolfi M, Curtin JF, Nichols WS, et al. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol. 2007;85(2):133–148. doi:10.1007/s11060-007-9400-9
   PubMed Web of Science ®Google Scholar
• Maqsood MI, Matin MM, Bahrami AR, et al. Immortality of cell lines: challenges and advantages of establishment. Cell Biol. Int. 2013;3:1–8.
   Google Scholar
• Wu H, Yang L, Liu H, et al. Exploring the efficacy of tumor electric field therapy against glioblastoma: an in vivo and in vitro study. CNS Neurosci Ther. 2021;27(12):1587–1604. doi:10.1111/cns.13750
   PubMed Web of Science ®Google Scholar
• Jiang N, Dai Q, Su X, et al. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. Mol Biol Report. 2020;47(6):4587–4629. doi:10.1007/s11033-020-05435-1
   PubMed Web of Science ®Google Scholar
• Jin Q, Zhao J, Zhao Z, et al. CAMK1D inhibits glioma through the PI3K/AKT/mTOR signaling pathway. Front Oncol. 2022;12:845036. doi:10.3389/fonc.2022.845036
   PubMedGoogle Scholar
• Li W, Du Q, Li X, et al. Eriodictyol inhibits proliferation, metastasis and induces apoptosis of glioma cells via PI3K/Akt/NF-κB signaling pathway. Front Pharmacol. 2020;11:114. doi:10.3389/fphar.2020.00114
   PubMed Web of Science ®Google Scholar
• Yang Y, Lv QJ, Du QY, Yang BH, Lin RX, Wang SQ. Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells’ growth in vitro and in vivo. World J Gastroenterol. 2005;11(16):2491–2496. doi:10.3748/wjg.v11.i16.2491
   PubMed Web of Science ®Google Scholar
• Yu J, Yang K, Zheng J, et al. Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression. Cell Death Dis. 2022;13(4):388. doi:10.1038/s41419-022-04745-5
   PubMed Web of Science ®Google Scholar
• Duarte D, Vale N. Evaluation of synergism in drug combinations and reference models for future orientations in oncology. Curr Res Pharmacol Drug Discov. 2022;3:100110. doi:10.1016/j.crphar.2022.100110
   PubMedGoogle Scholar
• Alshehri AF, KhodierAEAl-Gayyar MM, Al-Gayyar MM. Antitumor activity of ligustilide against Ehrlich solid carcinoma in rats via inhibition of proliferation and activation of autophagy. Cureus. 2023;15(6):e40499. doi:10.7759/cureus.40499
   PubMed Web of Science ®Google Scholar
• Ma H, Li L, Dou G, et al. Z-ligustilide restores tamoxifen sensitivity of ERa negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERa. Oncotarget. 2017;8(17):29328–29345. doi:10.18632/oncotarget.16440
   PubMedGoogle Scholar
• Hsu RJ, Peng KY, Hsu WL, et al. Z-ligustilide induces c-Myc-dependent apoptosis via activation of ER-stress signaling in hypoxic oral cancer cells. Front Oncol. 2022;12:824043. doi:10.3389/fonc.2022.824043
   PubMed Web of Science ®Google Scholar
• Bu X, Xia W, Wang X, et al. Butylphthalide inhibits nerve cell apoptosis in cerebral infarction rats via the JNK/p38 MAPK signaling pathway. Exper Ther Med. 2021;21(6):565. doi:10.3892/etm.2021.9997
   PubMed Web of Science ®Google Scholar
• Xu S, Li X, Li Y, et al. Neuroprotective effect of Dl-3-n-butylphthalide against ischemia-reperfusion injury is mediated by ferroptosis regulation via the SLC7A11/GSH/GPX4 pathway and the attenuation of blood-brain barrier disruption. Front Aging Neurosci. 2023;15:1028178.
   PubMed Web of Science ®Google Scholar
• Zhan L, Pang Y, Jiang H, et al. Butylphthalide inhibits TLR4/NF-κB pathway by upregulation of miR-21 to have the neuroprotective effect. J Healthcare Eng. 2022;2022:4687349. doi:10.1155/2022/4687349
   PubMed Web of Science ®Google Scholar
• Zhao DY, Yu DD, Ren L, et al. Ligustilide protects PC12 cells from oxygen-glucose deprivation/reoxygenation-induced apoptosis via the LKB1-AMPK-mTOR signaling pathway. Neul Regen Res. 2020;15(3):473–481. doi:10.4103/1673-5374.266059
   PubMed Web of Science ®Google Scholar
• Hafezi SRahmani M. Targeting BCL-2 in cancer: advances, challenges, and perspectives. Cancers. 2021;13:6.
   Web of Science ®Google Scholar
• Sharawi ZW. Therapeutic effect of Arthrocnemummachrostachyum methanolic extract on Ehrlich solid tumor in mice. BMC Compl Med Ther. 2020;20(1):153. doi:10.1186/s12906-020-02947-y
   PubMedGoogle Scholar
• Rahmani F, Ziaeemehr A, Shahidsales S, et al. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma. J Cell Physiol. 2020;235(5):4146–4152. doi:10.1002/jcp.29333
   PubMed Web of Science ®Google Scholar
• Zając A, Sumorek-Wiadro J, Langner E, et al. Involvement of PI3K pathway in glioma cell resistance to temozolomide treatment. Int J Mole Sci. 2021;22(10):5155. doi:10.3390/ijms22105155
   PubMed Web of Science ®Google Scholar